Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Mayo Clinic proceedings

• Publication date

  1999-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4065/74.11.1095PMID 10560596
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.

  1999cited by this paper
• Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.

  1999cited by this paper
• Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats.

  1998cited by this paper
• Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases.

  1998cited by this paper
• Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects.

  1998cited by this paper
• Carrageenan‐induced hyperalgesia is associated with increased cyclo‐oxygenase‐2 expression in spinal cord

  1997cited by this paper
• Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide.

  1997cited by this paper
• Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production.

  1997cited by this paper
• COX-1 and COX-2 tissue expression: implications and predictions.

  1997cited by this paper
• Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib).

  1997cited by this paper
• Prostaglandin endoperoxide H synthases-1 and -2.

  1996cited by this paper
• Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis.

  1996cited by this paper
• NSAID Gastropathy: A New Understanding

  1996cited by this paper
• Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts.

  1996cited by this paper
• Nonsteroidal antiinflammatory drug discontinuation in patients with osteoarthritis.

  1995cited by this paper
• Misoprostol Reduces Serious Gastrointestinal Complications in Patients with Rheumatoid Arthritis Receiving Nonsteroidal Anti-Inflammatory Drugs

  1995cited by this paper
• Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase.

  1995cited by this paper
• Quality improvement guidelines for the treatment of acute pain and cancer pain. American Pain Society Quality of Care Committee.

  1995cited by this paper
• Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology.

  1995cited by this paper
• Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.

  1994cited by this paper
• Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester.

  1994cited by this paper
• 3 – Biological Properties of Cyclooxygenase Products

  1994cited by this paper
• Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

  1994cited by this paper
• Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroidal anti-inflammatory drugs.

  1994cited by this paper
• Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.

  1994cited by this paper
• Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissues

  1993cited by this paper
• Dexamethasone inhibits mitogen induction of the TIS10 prostaglandin synthase/cyclooxygenase gene.

  1992cited by this paper
• Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing.

  1991cited by this paper
• Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee.

  1991cited by this paper
• The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes.

  1990cited by this paper
• The mechanisms of action of nonsteroidal antiinflammatory drugs.

  1989cited by this paper
• CONTROVERSIES IN THE DETECTION AND MANAGEMENT OF NONSTEROIDAL ANTIINFLAMMATORY DRUG‐INDUCED SIDE EFFECTS OF THE UPPER GASTROINTESTINAL TRACT

  1989cited by this paper
• Joint pain and quality of life; results of a randomised trial.

  1989cited by this paper
• Controversies in the detection and management of nonsteroidal antiinflammatory drug-induced side effects of the upper gastrointestinal tract.

  1989cited by this paper
• Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee.

  1988cited by this paper
• Indexes of severity for osteoarthritis of the hip and knee. Validation--value in comparison with other assessment tests.

  1987cited by this paper
• Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.

  1986cited by this paper
• Problems associated with pain measurement in arthritis: comparison of the visual analogue and verbal rating scales.

  1984cited by this paper
• Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases

  1983cited by this paper
• An articular index for the assessment of osteoarthritis.

  1981cited by this paper
• Printed in Great Britain

  1970cited by this paper
• A SEVEN-DAY VARIABILITY STUDY OF 499 PATIENTS WITH PERIPHERAL RHEUMATOID ARTHRITIS.

  1965cited by this paper
• A Seven‐Day variability study of 499 patients with peripheral rheumatoid arthritis

  1965cited by this paper
• Therapeutic criteria in rheumatoid arthritis.

  1949cited by this paper

• Different dosing regimens for chronic knee osteoarthritis (KOA) pain management: A pooled analysis on celecoxib

  2026cites this paper
• Efficacy and Safety of Celecoxib and a Korean SYSADOA (JOINS) for the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis

  2025cites this paper
• Natural Eggshell Membrane Attenuates Chondrocyte Inflammation and Surgically Induced Osteoarthritis in Rats

  2024cites this paper
• Renal effects of selective cyclooxygenase-2 inhibitor anti-inflammatory drugs: A systematic review and meta-analysis

  2024cites this paper
• Synergistic celecoxib and dimethyl-celecoxib combinations block cervix cancer growth through multiple mechanisms

  2024cites this paper
• Effects of Analgesics on Self-Reported Physical Function and Walking Ability in People With Hip or Knee Osteoarthritis: A Systematic Review and Meta-Analysis

  2023cites this paper
• OSTEOARTHRITIS OF KNEE JOINTS: THE EFFECT OF CONCOMITANT THERAPY IN COMORBID PATHOLOGY

  2023cites this paper
• 3D Bioprinted Silk‐Based In Vitro Osteochondral Model for Osteoarthritis Therapeutics

  2022cites this paper
• Systematic Review on Nonopioid Pharmacologic Treatments for Chronic Pain: Surveillance Report 1

  2022cites this paper
• A Comprehensive Review of Celecoxib Oral Solution for the Acute Treatment of Migraine.

  2022cites this paper
• Effect of Low dose Naltrexone versus Naproxen Extended-release for Pain Relief in knee osteoarthritis, a Triple-blinded, Non-inferiority Phase II Randomized Controlled Trial (FREEDOM) - Study Protocol

  2021cites this paper
• Non-Steroidal Anti-Inflammatory Drugs Increase Cisplatin, Paclitaxel, and Doxorubicin Efficacy against Human Cervix Cancer Cells

  2020cites this paper
• Duration of Symptom Relief and Early Trajectory of Adverse Events for Oral Nonsteroidal Antiinflammatory Drugs in Knee Osteoarthritis: A Systematic Review and Meta‐Analysis

  2020cites this paper
• Renoprotective effect of celecoxib against gentamicin-induced nephrotoxicity through suppressing NFκB and caspase-3 signaling pathways in rats.

  2020cites this paper
• Clinical effect of intramuscular calcitonin compared with oral celecoxib in the treatment of knee bone marrow lesions: a retrospective study

  2020cites this paper
• Nonopioid Pharmacologic Treatments for Chronic Pain

  2020cites this paper
• Non-operative treatment options for knee osteoarthritis.

  2019cites this paper
• Antioxidant and anti-inflammatory dietary supplements in the treatment of osteoarthritis: a scoping review

  2019cites this paper
• Safety of Cyclooxygenase-2 Inhibitors in Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis

  2019cites this paper
• Bioavailability enhancement of poorly soluble drugs: The holy grail in pharma industry.

  2019cites this paper
• Nonsteroidal Anti-Inflammatory Drug-Gastropathy and Enteropathy

  2019cites this paper
• Celecoxib for the treatment of musculoskeletal arthritis

  2019cites this paper
• First-in-human randomized clinical trials of the safety and efficacy of tanezumab for treatment of chronic knee osteoarthritis pain or acute bunionectomy pain

  2018cites this paper
• Simultaneous determination of parecoxib and its main metabolites valdecoxib and hydroxylated valdecoxib in mouse plasma with a sensitive LC–MS/MS method to elucidate the decreased drug metabolism of tumor bearing mice

  2018cites this paper
• The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial.

  2018cites this paper
• Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: a model-based evaluation.

  2018cites this paper
• Gastrointestinal Complications of Antirheumatic Drugs

  2017cites this paper
• Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

  2017cites this paper
• Effects of oral glucosamine hydrochloride and mucopolysaccharide protein in a rabbit model of osteoarthritis

  2017cites this paper
• Retraction and republication-Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of osteoarthritis pain: a network meta-analysis.

  2017cites this paper
• Efficacy of celecoxib versus ibuprofen for the treatment of patients with osteoarthritis of the knee: A randomized double-blind, non-inferiority trial

  2017cites this paper
• Comparing the Safety and Efficacy of Celecoxib for the Treatment of Osteoarthritis in Asian and non-Asian Populations: An Analysis of Data from Two Randomized, Double-blind, Placebo-controlled, Active-comparator Trials

  2017cites this paper
• What is the impact of treatment for hepatitis C virus infection?

  2017cites this paper
• Celecoxib for osteoarthritis.

  2017cites this paper
• Nonoperative management of cervical disc herniations: An evidence-based approach

  2016cites this paper
• Original article: EFFICACY OF ELAEAGNUS ANGUSTIFOLIA EXTRACT IN THE TREATMENT OF KNEE OSTEOARTHRITIS: A RANDOMIZED CONTROLLED TRIAL

  2016cites this paper
• Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study

  2016cites this paper
• Examination of overall treatment effect and the proportion attributable to contextual effect in osteoarthritis: meta-analysis of randomised controlled trials

  2016cites this paper
• Effects of intra-articular SHINBARO treatment on monosodium iodoacetate-induced osteoarthritis in rats

  2016cites this paper
• Efficacy and Safety of Celecoxib Therapy in Osteoarthritis

  2016cites this paper
• Efficacy of Elaeagnus Angustifolia extract in the treatment of knee osteoarthritis: a randomized controlled trial

  2016cites this paper
• Effect of Hijikia fusiforme extracts on degenerative osteoarthritis in vitro and in vivo models

  2016cites this paper
• Glucosamina y sulfato de condroitina en el tratamiento de la osteoartritis

  2016cites this paper
• Relative efficacy and tolerability of etoricoxib, celecoxib, and naproxen in the treatment of osteoarthritis

  2016cites this paper
• Does flare trial design affect the effect size of non-steroidal anti-inflammatory drugs in symptomatic osteoarthritis? A systematic review and meta-analysis

  2016cites this paper
• New COX-2 Inhibitors

  2016cites this paper
• Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities.

  2016cites this paper
• Anti-arthritic agents: progress and potential.

  2015cites this paper
• Comparison between 200 mg QD and 100 mg BID oral celecoxib in the treatment of knee or hip osteoarthritis

  2015cites this paper
• Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury

  2015cites this paper
• Lifetime Medical Costs of Knee Osteoarthritis Management in the United States: Impact of Extending Indications for Total Knee Arthroplasty

  2015cites this paper
• Effectiveness and Implications of Alternative Placebo Treatments

  2015cites this paper
• Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

  2015cites this paper
• Immunomodulation by interleukin-10 overexpressing mesenchymal stem cells for cartilage repair in osteoarthritis

  2015cites this paper
• Response to: ‘Does MOVES move the needle?’ by Dr Meyer

  2015cites this paper
• Cyclooxygenase‐2 inhibitor suppresses tumour progression of prostate cancer bone metastases in nude mice

  2014cites this paper
• The efficacy of duloxetine, non-steroidal anti-inflammatory drugs, and opioids in osteoarthritis: a systematic literature review and meta-analysis

  2014influential citation
• Drug-free gel containing ultra-deformable phospholipid vesicles (TDT 064) as topical therapy for the treatment of pain associated with osteoarthritis: a review of clinical efficacy and safety

  2014cites this paper
• Tulsi oil as a potential penetration enhancer for celecoxib transdermal gel formulations

  2014cites this paper
• COST-EFFECTIVENESS OF GLUCOSAMINE, CHONDROITIN SULFATE, THEIR COMBINATION, CELECOXIB, NON-SELECTIVE NON- STEROIDAL ANTI-INFLAMMATORY DRUGS, AND PLACEBO IN TREATING KNEE OSTEOARTHRITIS

  2014cites this paper
• Pharmacologic regimens for knee osteoarthritis prevention: can they be cost-effective?

  2014cites this paper
• Cardiovascular risk associated with celecoxib or etoricoxib: a meta-analysis of randomized controlled trials which adopted comparison with placebo or naproxen.

  2014cites this paper
• Effects of Elaeagnus angustifolia L. supplementation on serum levels of inflammatory cytokines and matrix metalloproteinases in females with knee osteoarthritis.

  2014cites this paper
• Efficacy and tolerability of celecoxib in osteoarthritis patients who previously failed naproxen and ibuprofen: results from two trials

  2014cites this paper
• Cardiovascular Risk with Non-steroidal Anti-inflammatory Drugs: Clinical Implications

  2014cites this paper
• 보스웰리아 추출물의 골관절염 억제 효과 연구

  2014cites this paper
• A Combination of Scutellaria Baicalensis and Acacia Catechu Extracts for Short-Term Symptomatic Relief of Joint Discomfort Associated with Osteoarthritis of the Knee

  2014cites this paper
• Evaluación económica del uso de duloxetina en el tratamiento del dolor crónico causado por osteoartritis de rodilla en el sistema privado de salud en México

  2014cites this paper
• Effect of Boswellia serrata Extracts on Degenerative Osteoarthritis in vitro and in vivo Models

  2014cites this paper
• Assessing the cardiovascular risk between celecoxib and nonselective nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis and osteoarthritis.

  2014cites this paper
• Efficacy and tolerability of celecoxib and naproxen versus placebo in Hispanic patients with knee osteoarthritis

  2014cites this paper
• A parallel-group comparison study of celecoxib with loxoprofen sodium in third mandibular molar extraction patients.

  2014cites this paper
• Efficacy and tolerability of naproxen/esomeprazole magnesium tablets compared with non-specific NSAIDs and COX-2 inhibitors: a systematic review and network analyses

  2013cites this paper
• A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis.

  2013cites this paper
• Cost-Effectiveness Analyses of Osteoarthritis Oral Therapies: a Systematic Review

  2013cites this paper
• Safety of celecoxib compared with placebo and non-selective NSAIDs: cumulative meta-analysis of 89 randomized controlled trials

  2013cites this paper
• PENAMBATAN MOLEKULER KURKUMIN DAN ANALOGNYA PADA ENZIM SIKLOOKSIGENASE-2 Molecular Docking of Curcumin and It's Analoque on Cyclooxigenase-2 Enzyme

  2013cites this paper
• A Review on the Management of Hip and Knee Osteoarthritis

  2013cites this paper
• Efficacy and safety of short-term use of COX-2 inhibitors in patients after an acute stroke with musculoskeletal pain

  2013cites this paper
• Simultaneous Liquid Chromatographic Determination of Two Co- Prescribed Anti-Cancer Drugs in Bulk Drug, Dosage Formulations and in Human Serum Using Multivariate Technique: Application to in vitro Drug Interaction

  2013cites this paper
• A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint.

  2013cites this paper
• Celecoxib and Diclofenac Plus Omeprazole are Similarly Effective in the Treatment of Arthritis in Patients at High GI Risk in the CONDOR Trial§

  2013cites this paper
• Potentiality and safety assessment of combination therapy with silymarin and celecoxib in osteoarthritis of rat model

  2013cites this paper
• Experimental Models of Prostate Cancer Bone Metastasis - Establishment, characterization and imaging of xenograft bone metastasis models -

  2013cites this paper
• Efficacy of Rofecoxib, Celecoxib, and Acetaminophen in Osteoarthritis of the Knee

  2013cites this paper
• Management of Spondyloarthropathy

  2012cites this paper
• Innovations in Post-Marketing Safety Research

  2012cites this paper
• A Randomised, Double-Blind, Clinical Trial Comparing the Efficacy of Nimesulide, Celecoxib and Rofecoxib in Osteoarthritis of the Knee

  2012cites this paper
• Nonsteroidal Anti-inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, and Agents Used in Gout

  2012cites this paper
• Economic Evaluation of Celecoxib, a New Cyclo-Oxygenase 2 Specific Inhibitor, in Switzerland

  2012cites this paper
• Efficacy of Etoricoxib, Celecoxib, Lumiracoxib, Non-Selective NSAIDs, and Acetaminophen in Osteoarthritis: A Mixed Treatment Comparison

  2012influential citation
• Celecoxib

  2012cites this paper
• Efficacy and safety of celecoxib versus diclofenac and omeprazole in elderly arthritis patients: a subgroup analysis of the CONDOR trial

  2012cites this paper
• Pharmaceutical Therapy for Osteoarthritis

  2012cites this paper
• Response to Nonsteroidal Anti-inflammatory Drugs in African Americans with Osteoarthritis of the Knee a

  2012cites this paper
• A Framework for Evaluating the Clinical Consequences of Initial Therapy with NSAIDs, NSAIDs plus Gastroprotective Agents, or Celecoxib in the Treatment of Arthritis

  2012cites this paper
• An Economic Model for Determining the Costs and Consequences of Using Various Treatment Alternatives for the Management of Arthritis in Canada

  2012cites this paper
• Patient Nonadherence in Clinical Trials: Could There Be a Link to Postmarketing Patient Safety?

  2012cites this paper
• Efficacy and Tolerability of Celecoxib versus Naproxen in Patients with Osteoarthritis of the Knee: A Randomized, Double-Blind, Double-Dummy Trial

  2012cites this paper
• Efficacy of celecoxib, meloxicam and paracetamol in elderly Kashin-Beck Disease (KBD) patients

  2011cites this paper